GSK builds oncology pipeline as drug shown to help myeloma patients
Two doses of belantamab mafodotin helped subdue disease in adults who received three prior treatments for multiple myeloma
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
myeloma
New blockbuster drugs will push multiple myeloma treatment market to $22.4 bn by 2023
The increase will be boosted by increasing therapeutic options, including the introduction of two monoclonal antibodies with…